Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14356/817Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ryan, Edward T | - |
| dc.date.accessioned | 2016-01-28T20:10:36Z | - |
| dc.date.accessioned | 2022-11-08T10:23:58Z | - |
| dc.date.available | 2016-01-28T20:10:36Z | - |
| dc.date.available | 2022-11-08T10:23:58Z | - |
| dc.date.issued | 2016-01-19 | - |
| dc.identifier.uri | http://103.69.126.140:8080/handle/20.500.14356/817 | - |
| dc.description.abstract | In The Lancet Infectious Diseases, Amit Arjyal and colleagues report the results from their randomised clinical trial comparing gatifl oxacin with ceftriaxone for patients with uncomplicated enteric fever in Nepal. Their two main fi ndings are sobering. First, they suggest that fl uoroquinolones should no longer be recommended as front-line empirical treatment for individuals with enteric fever in Nepal. Second, a large proportion of individuals in Nepal who are syndromically characterised as having uncomplicated enteric fever probably have an alternative diagnosis. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | Lancet Infect Dis 2016 | en_US |
| dc.subject | Enteric Fever: | en_US |
| dc.title | Troubling news from Asia about treating enteric fever: a coming storm | en_US |
| dc.type | Technical Report | en_US |
| Appears in Collections: | Research Abstract | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Troubling news from Asia about treating enteric fever.pdf | Full Text Down Load. | 101.8 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.